Prevention and Treatment of Chemotherapy-Induced Neutropenia with the Biosimilar Filgrastim: A Non-Interventional Observational Study of Clinical Practice Patterns

Publisher： Karger

E-ISSN： 2296-5262|38|4|146-152

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.4, 2015-03, pp. : 146-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MONITOR‐GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy‐induced/febrile neutropenia prophylaxis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 241-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis

By  

Oncology Research and Treatment, Vol. 38, Iss. 5, 2015-05 ,pp. : 221-229

Karger

Access to resources Recommend Favorite

Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice

By Heinz Werner J.   Silling Gerda   Böhme Angelika  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 335-342

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine in the Routine Treatment of Advanced Breast Cancer: Results from a Non-Interventional Observational Study in 876 Patients

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 631-636

Karger

Access to resources Recommend Favorite

A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 504-511

Karger

Access to resources Recommend Favorite